Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1979 7
1980 2
1981 6
1982 5
1983 7
1984 9
1985 6
1986 9
1987 5
1988 6
1989 6
1990 6
1991 3
1992 2
1993 2
1994 2
1995 3
1996 3
1997 3
1998 2
1999 3
2000 5
2001 7
2002 5
2003 9
2004 4
2005 6
2006 7
2007 8
2008 14
2009 3
2010 5
2011 4
2012 2
2013 5
2014 10
2015 10
2016 14
2017 10
2018 6
2019 10
2020 8
2021 8
2022 5
2023 9
2024 10
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C, Gentile D, Gatzemeier W, Sagona A, Barbieri E, Testori A, Errico V, Bottini A, Marrazzo E, Dani C, Dozin B, Boni L, Bruzzi P, Fernandes B, Franceschini D, Spoto R, Torrisi R, Scorsetti M, Santoro A, Canavese G; SINODAR-ONE Collaborative Group. Tinterri C, et al. Ann Surg Oncol. 2022 Sep;29(9):5732-5744. doi: 10.1245/s10434-022-11866-w. Epub 2022 May 12. Ann Surg Oncol. 2022. PMID: 35552930 Clinical Trial.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group. Tinterri C, et al. Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215. Br J Surg. 2023. PMID: 37471574 Free PMC article. Clinical Trial.
Flecainide and encainide.
Furlanello F, Vergara G, Bettini R, Mosna G, Gramegna L, Disertori M. Furlanello F, et al. Among authors: bettini r. Eur Heart J. 1987 Mar;8 Suppl A:33-40. doi: 10.1093/eurheartj/8.suppl_a.33. Eur Heart J. 1987. PMID: 3107989 Review.
[Essential thrombocythemia].
Bettini R, Sala D, Gorini M. Bettini R, et al. Clin Ter. 2005 May-Jun;156(3):125-9. Clin Ter. 2005. PMID: 16048033 Review. Italian.
Novel platforms for oral drug delivery.
Colombo P, Sonvico F, Colombo G, Bettini R. Colombo P, et al. Among authors: bettini r. Pharm Res. 2009 Mar;26(3):601-11. doi: 10.1007/s11095-008-9803-0. Epub 2009 Jan 9. Pharm Res. 2009. PMID: 19132514 Review.
Recent Patents on Nasal Vaccines Containing Nanoadjuvants.
Candela F, Quarta E, Buttini F, Ancona A, Bettini R, Sonvico F. Candela F, et al. Among authors: bettini r. Recent Adv Drug Deliv Formul. 2022;16(2):103-121. doi: 10.2174/2667387816666220420124648. Recent Adv Drug Deliv Formul. 2022. PMID: 35450539 Free PMC article.
Dry powder formulations of hyperimmune serum.
Bianchera A, Donofrio G, Sonvico F, Bettini R. Bianchera A, et al. Among authors: bettini r. Drug Deliv Transl Res. 2024 Jul 31. doi: 10.1007/s13346-024-01678-8. Online ahead of print. Drug Deliv Transl Res. 2024. PMID: 39085576
261 results